Perioperative Myocardial Damage and Heart Failure in Noncardiac Surgery. Part 2. Reduction of the Risk of Perioperative Cardiac Complications by Pharmacological Measures and Optimization of Anesthetic and Critical Care Support (Review)

The second part of the overview presents and analyzes the current data on the methods of adjuvant pharmacological cardioprotection and possibilities of optimizing the anesthetic support and perioperative monitoring in high cardiac risk patients. Amendments made in international guidelines for the last 2–3 years on the basis of conclusive studies and meta-analyses have been examined. Cardioprotection mechanisms and information about its implementation in real clinical practice have been analysed. It has been shown that by no means all drugs under discussion can be widely used for prophytlactic purposes. Contemporary evidencebased recommendations concerning the optimization of anesthetic support and perioperative monitoring are given. A conclusion has been made that practical implementation of a comprehensive strategy aimed at reduction of the risk of cardiac complications might ensure decrease of both the incidence of severe cardiac complications and mortality due to them.

perioperative cardiac complications, non-cardiac surgeries, pharmacological cardioprotection, cardioprotection mechanisms, myocardial ischemia prophylaxis, anesthetic preconditioning

1. Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D.; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur. Heart J. 2019; 40 (3): 237269. DOI: 10.1093/eurheartj/ehy462. PMID: 30165617

2. Devereaux P.J., Goldman L., Cook D.J., Gilbert K., Leslie K., Guyatt G.H. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005; 173 (6): 627-634. DOI: 10.1503/cmaj.050011. PMID: 16157727

3. Devereaux P.J., Sessler D.I. Cardiac complications and major noncardiac surgery. N. Engl. J. Med. 2016; 374 (14): 1394-1395. DOI: 10.1056/NEJMc1516761. PMID: 27050228

4. Devereaux P.J. Suboptimal outcome of myocardial infarction after noncardiac surgery: physicians can and should do more. Circulation. 2018; 137 (22): 2340-2343. DOI: 10.1161/CIRCULATIONAHA. 118.033766. PMID: 29844070

5. P OISE Study Group, Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J.C., Xavier D., Chrolavicius S., Greenspan L., Pogue J., Pais P., Liu L., Xu S., Málaga G., Avezum A., Chan M., Montori V.M., Jacka M., Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISEtrial): a randomised controlled trial. Lancet. 2008; 371 (9627): 1839-1847. DOI: 10.1016/S0140-6736 (08)60601-7. PMID: 18479744

6. Moroz V.V., Dobrushina O.R., Strelnikova E.P., Kornienko A.N., Zinina E.P. Predictors of сardiac сomplications of abdominal and small pelvic surgery in elderly and senile patients. Obshchaya Reanimatologiya = General Reanimatology. 2011; 7 (5): 26–31. DOI: 10.15360/1813-9779-2011-5-26. [In Russ]

7. Dobrushina O.R., Kornienko A.N., Shklovsky B.L., Tsarev M.I. Risk assessment of cardiac complications in extensive abdominal operations in patients of elderly and senile age. Rossiisky Meditsinsky Zhurnal. 2012; 1: 14–18. [In Russ]

8. Zabolotskikh I.B., Gorobets E.S., Grigoryev E.V., Kozlov I.A., Lebedinsky K.M., Musaeva T.S., Ovechkin A.M., Trembach N.V., Khoronenko V.E. Perioperative management of geriatric patients. Draft clinical guidelines of the Federation of anesthetists of the Russian Federation.. Vestnik Intensivnoi Terapii Imeni A.I.Saltanova. 2018; 1: 60-74. DOI: 10.21320/1818-474X-2018-1-60-74. [In Russ]

9. Kristensen S.D., Knuuti J., Saraste A., Anker S., Bøtker H.E., Hert S.D., Ford I., Gonzalez-Juanatey J.R.,Gorenek B., Heyndrickx G.R., Hoeft A., Huber K., Iung B., Kjeldsen K.P., Longrois D., Lüscher T.F., Pierard L., Pocock S., Price S., Roffi M., Sirnes P.A., Sousa-Uva M., Voudris V., Funck-Brentano C.; Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur. Heart J. 2014; 35 (35): 2383-2431. DOI: 10.1093/eurheartj/ ehu282. PMID: 25086026

10. Alvarez Escudero J., Calvo Vecino J.M., Veiras S., García R., González A.; Working Group of the CPG. Clinical Practice Guideline (CPG). Recommention strategy for reducing risk of heart failure patientsrequiring noncardiac surgery: reducing risk of heartfailure patients in noncardiac surgery. Rev. Esp. Anestesiol. Reanim. 2015; 62 (7): 359-419. DOI: 10.1016/j.redar.2015.05.002. PMID: 26164471

11. De Hert S., Staender S., Fritsch G., Hinkelbein J., Afshari A., Bettelli G., Bock M., Chew M.S., Coburn M., De Robertis E., Drinhaus H., Feldheiser A., Geldner G., Lahner D., Macas A., Neuhaus C., Rauch S., SantosAmpuero M.A., Solca M., Tanha N., Traskaite V., Wagner G., Wappler F. Preоperative evaluation of adults undergoing electivenoncardiac surgery: updated Guideline from the European Society of Anaesthesiology. Eur. J. Anaesthesiol. 2018; 35 (6): 407-465. DOI: 10.1097/EJA.0000000000000817. PMID: 29708905

12. Duceppe E., Parlow J., MacDonald P., Lyons K., McMullen M., Srinathan S., Graham M., Tandon V., Styles K., Bessissow A., Sessler D.I., Bryson G., Devereaux P.J. Canadian Cardiovascular Society Guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can. J. Cardiol. 2017; 33 (1): 17-32. DOI: 10.1016/j.cjca.2016.09.008. PMID: 27865641

13. Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E.L., Fleischmann K.E., Freeman W.K., Froehlich J.B., Kasper E.K., Kersten J.R., Riegel B., Robb J.F., Smith S.C. Jr., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Buller C.E., Creager M.A., Ettinger S.M., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Lytle B.W., Nishimura R., Ornato J.P., Page R.L., Riegel B., Tarkington L.G., Yancy C.W. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J. Am. Coll.Cardiol. 2007; 50 (17): 1707-1732. DOI: 10.1016/j.jacc.2007. 9.001. PMID: 17950159

14. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine; Society for Vascular Surgery; Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E.L., Fleischmann K.E., Freeman W.K., Froehlich J.B., Kasper E.K., Kersten J.R., Riegel B., Robb J.F. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J. Am. Coll. Cardiol. 2009; 54 (22): e13e118. DOI: 10.1016/j.jacc.2009.07.010. PMID: 19926002

15. Shchukin Yu.V, Khokhlunov S.M., Surkova E.A., Duplyakov D.V., Vachev A.N., Germanov A.V., Zemlyanova M.E., Kruglov V.N., Kuzmin V.P., Lyas M.N., Pavlova G.A., Pavlova T.V., Polyakov V.P., Ryabov A.E., Skuratova M.A., Chomakhidze P.Sh., Shvarts Yu.G., Boitsov S.A., Veselkova N.S., Gendlin G.E., Glezer М.Г., Golitsyn S.P., Karpov Yu.A., Kobalava Zh.D., Konradi A.O., Kotovskaya Yu.V., Lebedev P.A., Lopatin Yu.M., Matyushin G.V., Moiseyev V.S., Oleinikov V.E., Perepech N.B., Pershukov I.V., Poltavskaya M.G., Sokolov I.M., Storozhakov G.I., Sulimov V.A., Tarlovskaya E.I., Chazova I.E., Chumakova G.A., Shalnova S.A., Shlyakhto E.V., Shutov A.M., Fomin I.V., Yavelov I.S. Perioperative management of patients with concomitant coronary artery disease. Clinical guidelines. Kardiovaskulyarnaya Terapiya i Profilaktika. 2011; 10 (6): Supplement 3: 1-28. [In Russ]

16. Writing Committee for the VISION Study Investigators; Devereaux P.J., Biccard B.M., Sigamani A., Xavier D., Chan M.T.V., Srinathan S.K., Walsh M., Abraham V., Pearse R., Wang C.Y., Sessler D.I., Kurz A., Szczeklik W., Berwanger O., Villar J.C., Malaga G., Garg A.X., Chow C.K., Ackland G., Patel A., Borges F.K., Belley-Cote E.P., Duceppe E., Spence J., Tandon V., Williams C., Sapsford R.J., Polanczyk C.A., Tiboni M., Alonso-Coello P., Faruqui A., Heels-Ansdell D., Lamy A., Whitlock R., LeManach Y., Roshanov P.S., McGillion M., Kavsak P., McQueen M.J., Thabane L., Rodseth R.N., Buse G.A.L., Bhandari M., Garutti I., Jacka M.J., Schünemann H.J., Cortes O.L., Coriat P., Dvirnik N., Botto F., Pettit S., Jaffe A.S., Guyatt G.H. Association of postoperative high-sensitivity Troponin levels with myocardial injury and 30-day ortality among patients undergoing noncardiac surgery. JAMA. 2017; 317 (16): 16421651. DOI: 10.1001/jama.2017.4360. PMID: 28444280

17. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G., Coats A.J., Falk V., González-Juanatey J.R., Harjola V.P., Jankowska E.A., Jessup M., Linde C., Nihoyannopoulos P., Parissis J.T., Pieske B., Riley J.P., Rosano G.M., Ruilope L.M., Ruschitzka F., Rutten F.H., van der Meer P.; Authors/Task Force Members. 2016 ESC Guidelines for the diagnosis and treatmentof acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 2016; 18 (8): 891-975. DOI: 10.1002/ejhf.592. PMID: 27207191

18. Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E. Jr., Colvin M.M., Drazner M.H., Filippatos G.S., Fonarow G.C., Givertz M.M., Hollenberg S.M., Lindenfeld J., Masoudi F.A., McBride P.E., Peterson P.N., Stevenson L.W., Westlake C. 2017 ACC/AHA/HFSA Focused Update of the 2013ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J. Card. Fail. 2017; 23 (8): 628-651. DOI: 10.1016/j.cardfail.2017.04.014. PMID: 28461259

19. Gilbert-Kawai E., Montgomery H. Cardiovascular assessment for noncardiac surgery: European guidelines. Br. J. Hosp. Med . (London). 2017; 78 (6): 327-332. DOI: 10.12968/hmed.2017.78.6.327

20. Krichevsky L.A. Opportunities and risks of perioperative cardioprotection with β-adrenergic receptor blockers.. In the book: Kozlov I.A., Yavorovsky A.G. (eds.). Adjuvant cardioprotection in cardiac patients.. Moscow: FarmEtika; 2017: 29-37. ISBN 978-5-9905473-2-2. [In Russ]

21. Royster R.L., Groban L., Grosshans D.W., Jones-Haywood M.M., Slaughter T.F. Cardiovascular pharmacology. In: Kaplan J.A., Reich D.L., Savino J.S. (eds.). Kaplan’s cardiac anesthesia. The echo era. 6-th ed. St. Louis: Saunders; 2011: 235-295. ISBN 9781437716177

22. Zabolotskikh I.B., Lebedinsky K.M., Grigoryev E.V., Grigoryev S.V., Gritsan A.I., Danilyuk P.I., Kirov M.Yu., Kozlov I.A., Kurapeyev I.S., Likhvantsev V.V., Mizikov V.M., Potievskaya V.I., Subbotin V.V. Perioperative management of patients with concomitant coronary artery disease. Clinical guidelines. 54-89. In the book: Zabolotskikh I.B., Shifman E.M. (eds.). Anesthesiology-reanimatology. Clinical guidelines. Moscow: GEOTAR-MediaМедиа; 2016: 960. ISBN 978-5-97044036-0. [In Russ]

23. Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., Sugarbaker D.J., Donaldson M.C., Poss R., Ho K.K., Ludwig L.E., Pedan A., Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100 (10): 1043-1049. DOI: 10.1161/01.CIR.100.10.1043. PMID: 10477528

24. Mangano D.T., Layug E.L., Wallace A., Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N. Engl. J. Med. 1996; 335 (23): 1713-1720. DOI: 10.1056/NEJM199612053352301. PMID: 8929262

25. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D.., Baars H.F., Yo T.I., Trocino G., Vigna C., Roelandt J.R., van Urk H. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N. Engl. J. Med. 1999; 341 (24): 1789-1794. DOI: 10.1056/NEJM199912093412402. PMID: 10588963

26. Wetterslev J., Juul A.B. Benefits and harms of perioperative beta-blockade. Best Pract. Res. Clin. Anaesthesiol. 2006; 20 (2): 285-302. DOI: 10.1016/j.bpa.2005.10.006. PMID: 16850778

27. Beattie W.S., Wijeysundera D.N., Karkouti K. McCluskey S., Tait G., Mitsakakis N., Hare G.M. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology. 2010; 112 (1): 25-33. DOI: 10.1097/ALN.0b013e3181c5dd81. PMID: 20032700

28. Khoronenko V.E., Osipova N.A., Butenko A.V., Pervova E.V., Drozdov I.V. Temporary pacing in the correction of drug-induced bradycardia. Obshchaya Reanimatologiya = General Reanimatology. 2007; 3 (5-6): 118-123. DOI: 10.15360/1813-9779-2007-6-118-123. [In Russ]

29. O’Neil-Callahan K., Katsimaglis G., Tepper M.R. Ryan J., Mosby C., Ioannidis J.P., Danias P.G. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J. Am. Coll. Cardiol. 2005; 45 (3): 336-342. DOI: 10.1016/j.jacc.2004.10.048. PMID: 15680709

30. Lomivorotov V.V., Efremov S.M., Abubakirov M.N., Merekin D.N. Should I cancel statins in the perioperative period? Vestnik Anesteziologii i Reanimatologii. 2018; 15 (4): 86-90. DOI: 10.21292/2078-5658-201815-4-86-90. [In Russ]

31. Wijeysundera D.N., Beattie W.S. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth. Analg. 2003; 97 (3): 634-641. DOI: 10.1213/01.ANE. 0000081732.51871.D2. PMID: 12933374

32. Kertai M.D.,Westerhout C.M., Varga K.S., Acsady G., Gal J. Dihydropiridine calcium channel blockers and peri-operative mortality in aortic aneurysm surgery. Br. J. Anaesth. 2008; 101 (4): 458–465. DOI: 10.1093/bja/aen173. PMID: 18556693

33. Kozlov I.A., Klypa T.V., Antonov I.O. Dexmedetomidine as a cardioprotector in cardiac surgery (review). Obshchaya Reanimatologiya = General Reanimatology. 2017; 13 (4): 46-63. DOI: 10.15360/18139779-2017-4-46-63. [In Russ, In Engl.]

34. Wijeysundera D.N., Bender J.S., Beattie W.S. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst Rev. 2009; 7 (4): CD004126. DOI: 10.1002/14651858.CD004126.pub2. PMID: 19821319

35. Duncan D., Sankar A., Beattie W.S., Wijeysundera D.N. Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery. Cochrane Database Syst Rev. 2018; 3: CD004126. DOI: 10.1002/14651858.CD004126.pub3. PMID: 29509957

36. Devereaux P.J., Sessler D.I., Leslie K., Kurz A., Mrkobrada M., AlonsoCoello P., Villar J.C., Sigamani A., Biccard B.M., Meyhoff C.S., Parlow J.L., Guyatt G., Robinson A., Garg A.X., Rodseth R.N., Botto F., Lurati Buse G., Xavier D., Chan M.T., Tiboni M., Cook D., Kumar P.A., Forget P., Malaga G., Fleischmann E., Amir M., Eikelboom J., Mizera R., Torres D., Wang C.Y., Vanhelder T., Paniagua P., Berwanger O., Srinathan S., Graham M., Pasin L., Le Manach Y., Gao P., Pogue J., Whitlock R., Lamy A., Kearon C., Chow C., Pettit S., Chrolavicius S.,Yusuf S.; POISE-2 Investigators. Clonidine in patients undergoing noncardiac surgery. N. Engl. J. Med. 2014; 370 (16): 1504-1513. DOI: 10.1056/NEJMoa1401106. PMID: 24679061

37. Soliman R., Zohry G. The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery. Ann. Card. Anaesth. 2016; 19 (4): 606-613. DOI: 10.4103/09719784.191570. PMID: 27716690

38. Jin S., Zhou X. Influence of dexmedetomidine on cardiac complications in non-cardiac surgery: a meta-analysis of randomized trials. Int. J. Clin. Pharm. 2017; 39 (4): 629-640. DOI: 10.1007/s11096-0170493-8. PMID: 28660467

39. Peng K., Ji F., Liu H., Zhang J., Chen Q., Jiang Y. Effects of perioperative dexmedetomidine on postoperative mortality and morbidity: a systematic review and meta-analysis. Clin. Ther. 2019; 41 (1): 138154.e4. DOI: 10.1016/j.clinthera.2018.10.022. PMID: 30528108

40. Lau W.C., Froehlich J.B., Jewell E.S., Montgomery D.G., Eng K.M., Shields T.A., Henke P.K., Eagle K.A. Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery. Ann. Vasc. Surg. 2013; 27 (4): 537–545. DOI : 10.1016/j.avsg.2012.12.001. PMID: 23535525

41. Devereaux P.J., Duceppe E., Guyatt G., Tandon V., Rodseth R., Biccard B.M., Xavier D., Szczeklik W., Meyhoff C.S., Vincent J., Franzosi M.G., Srinathan S.K., Erb J., Magloire P., Neary J., Rao M., Rahate P.V., Chaudhry N.K., Mayosi B., de Nadal M., Iglesias P.P., Berwanger O., Villar J.C., Botto F., Eikelboom J.W., Sessler D.I., Kearon C., Pettit S., Sharma M., Connolly S.J., Bangdiwala S.I., Rao-Melacini P., Hoeft A., Yusuf S.; MANAGE Investigators. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018; 391 (10137): 2325-2334. DOI: 10.1016/S0140-6736 (18)30832-8. PMID: 29900874

42. Eremenko A.A., Rybka M.M. Anti-ischemic and cardioprotective effects of levosimendan. In the book: Kozlov I.A., Yavorovsky A.G. (eds.). Adjuvant cardioprotection in cardiac patients. Moscow: FarmEtika; 2017: 125-141. ISBN 978-5-9905473-2-2. [In Russ]

43. Pollesello P., Parissis J., Kivikko M., Harjola V.P. Levosimendan metaanalyses: Is there a pattern in the effect on mortality? Int. J. Cardiol. 2016; 209: 77-83. DOI: 10.1016/j.ijcard.2016.02.014. PMID: 26882190

44. Morelli A., Ertmer C., Pietropaoli P., Westphal M. Reducing the risk of major elective non-cardiac surgery: is there a role for levosimendan in the preoperative optimization of cardiac function? Curr. Drug Targets. 2009; 10 (9): 863-871. DOI: 10.2174/138945009789108819. PMID: 19799540

45. Katsaragakis S., Kapralou A., Markogiannakis H., Kofinas G., Theodoraki E.M., Larentzakis A., Menenakos E., Theodorou D. Preoperative levosimendan in heart failure patients undergoing noncardiac surgery. Neth. J. Med. 2008; 66 (4): 154-159. PMID: 18424862

46. Ponschab M., Hochmair N., Ghazwinian N., Mueller T., Plöchl W. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair. Eur. J. Anaesthesiol. 2008; 25 (8): 627-633. DOI: 10.1017/S0265021508004080. PMID: 18405408

47. Likhvantsev V.V., Ubasev Yu.V., Skripkin Yu.V., Zabelina T.S., Sungurov V.A., Lomivorotov V.V., Marchenko D.N. Preoperative prevention of heart failure in noncardiac surgery. Obshchaya Reanimatologiya = General Reanimatology. 2016; 12 (3): 48-61. DOI: 10.15360/18139779-2016-3-48-61. [In Russ, In Engl.]

48. De Hert S.G., Turani F., Mathur S., Stowe D.F. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth. Analg. 2005; 100 (6): 1584–1593. DOI: 10.1213/01.ANE.0000153483.61170.0C. PMID: 15920178

49. Likhvantsev V.V., Grebenchikov O.A. Anesthetic preconditioning. In: Kozlov I.A., Yavorovsky A.G. (eds.). Adjuvant cardioprotection in cardiac patients. Moscow: FarmEtika; 2017: 38-69. ISBN 978-5-99054732-2. [In Russ]

50. Likhvantsev V.V., Timoshin S.S., Grebenchikov O.A., Shaposhnikov A.A., Skripkin Yu.V., Borisov K.Yu. The clinical significance of anesthetic preconditioning in high-risk patients in non-cardiac surgery. Vestnik Anesteziologii i Reanimatologii. 2012; 9 (3): 3-7. [In Russ]

51. Van Allen N.R., Krafft P.R., Leitzke A.S., Applegate R.L.2nd, Tang J., Zhang J.H. The role of volatile anesthetics in cardioprotection: a systematic review. Med. Gas. Res. 2012; 2 (1): 22. DOI: 10.1186/20459912-2-22. PMID: 22929111

52. Khapii Kh.Kh., Filippovskaya Zh.S., Khapii I.Kh., Lopatin A.F. Evaluation of the effectiveness of neoton in the postoperative period. Vestnik Intensivnoi Terapii. 2011; 4: 34-37. [In Russ]

53. Kozlov I.A., Yavorovsky A.G. Creatine phosphate as cardioprotector in sugery and intensive cardiology. Analytical review. Meditsinsky Alfavit. 2018; 9: 18-27. [In Russ]

54. Landoni G., Zangrillo A., Lomivorotov V.V., Likhvantsev V., Ma J., De Simone F., Fominskiy E. Cardiac protection with phosphocreatine: a meta-analysis. Interact. Cardiovasc. Thorac. Surg. 2016; 23 (4): 637646. DOI: 10.1093/icvts/ivw171. PMID: 27318357

55. Derbugov V.N., Potapov A.L., Potievskaya V.I., Khmelevskaya Ya.M. Exogenous phosphocreatine application in elderly and senile patients operated for colorectal cancer. Obshchaya Reanimatologiya = General Reanimatology. 2017; 13 (4): 38-45. DOI: 10.15360/18139779-2017-4-38-45. [In Russ, In Engl.]

56. Mastroroberto P., Chello M., Zofrea S., Bevacqua E., Marchese A.R. Cardioprotective effects of phosphocreatine in vascular surgery. Vasc. Endovasc. Surg. 1995; 29 (4): 255-260. DOI: 10.1177/153857449502900401

57. Mangano D.T., Browner W.S., Hollenberg M., London M.J., Tubau J.F., Tateo I.M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N. Engl. J. Med. 1990; 323 (26): 1781-1788. DOI: 10.1056/NEJM199012273232601. PMID: 2247116

58. Frank S.M., Fleisher L.A., Breslow M.J., Higgins M.S., Olson K.F., Kelly S., Beattie C. Perioperative maintenance of normothermia reducesthe incidence of morbid cardiac events. A randomizedclinical trial. JAMA. 1997; 277 (14): 1127-1134. DOI: 10.1001/jama.1997.03540380041029. PMID: 9087467

59. Kuzkov V.V., Kirov M.Yu. Invasive hemodynamic monitoring of hemodynamics in intensive care and anesthesiology.Arkhangelsk: Severnyi Gosudarstvennyi Meditsinsky Universitet. 2008: 244. ISBN 978-586279-178-5. [In Russ]

60. Arulkumaran N., Corredor C., Hamilton M.A., Ball J., Grounds R.M., Rhodes A., Cecconi M. Cardiac complications associated with goaldirected therapy in high-risk surgical patients: a meta-analysis. Br. J. Anaesth. 2014; 112 (4): 648-659. DOI: 10.1093/bja/aet466. PMID: 24413429

61. Thygesen K., Mair J., Katus H., Plebani M., Venge P., Collinson P., Lindahl B., Giannitsis E., Hasin Y., Galvani M., Tubaro M., Alpert J.S., Biasucci L.M., Koenig W., Mueller C., Huber K., Hamm C., Jaffe A.S.; Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur. Heart J. 2010; 31 (18): 2197-2204. DOI: 10.1093/eurheartj/ehq251. PMID: 20685679